just picked this from ihub a great post Anthony from

New Post Public Reply Private Reply Replies (1) Message Board
crazyjogger925
1,256
just picked this from ihub a great post


Anthony from yahoo forum posted the comment below. The frontline doctor has the same sentiment as my friend ER doc.

"I am pretty confident I have talked to more front line docs and advanced practice providers who are in the middle of treating these patients, and I have as hell talked to more than Adam FF. Below are pasted emails from a doc on the east coast who's been in the middle of this and who has a huge social media following. He says the same thing every single provider I've talked to: Rem is NOT working. Maybe just maybe that's what it's stock has not done anything despite the massive hype.
Here is the first email:
Hi Anthony,
Thanks for the message. I have learned not to follow anyone and do the research myself. I am almost done with a MBA in healthcare management at University of Mass so I have been learning how to analyze things for myself. But most importantly, I am hoping my medical background can help me objectively look at the data and see what works or doesn’t.
Leronlimab is not some miracle drug but it is going to be more effective than remdesivir and HCQ. I have raw data from ICUs at a few hospitals in the northeast US. It is a national tragedy to see our physicians stop critically thinking and throw something against the wall and hoping it would stick.
I am doing my best getting Leronlimab out in my physician circles. I am unconventional physician, very conservative in my management of patients but aggressive when I need to. I believe in proactive medicine, not reactive medicine like a majority of physicians are practicing.
Thanks for the message.
Here is the second one that he sent after reviewing some of the Leron data:
Tony-
Thanks for sharing your sentiments.
I knew hydroxychloroquine and azithromycin was ineffective when it first came out and many of my colleagues said the same thing. But they were pressured to give it because they felt that had to give something.
Remdesivir and tocilizumab have been given last several weeks and they are not effective. In fact many of our sickest COVID patients have liver damage from the RANTES induced cytokine storm. So they can’t get remdesivir and tocilizumab because of the liver damage! Doctors then are left with nothing and many refuse to consider Leronlimab. They say we don’t have data but there is knowledge from the HIV trials which are on the NIH page! If not Leronlimab, then what do you propose? ‘Supportive management’. That means cross our fingers and pray the patient doesn’t die!!!
Doctor’s have become technicians and stopped being physicians. ARDS: Low tidal volume, FiO2 of 70%, increase the PEEP, do some proning. That is what their checklist says! And when it fails, start sweating and hope the patient dies quickly or they make a quick recover!
Unfortunately many of my colleagues practice reactive medicine instead of being proactive! We are at war with this virus and during any war deception is key! We have to anticipate the virus next move and have our defenses up and ready! Instead we are CHASING the virus and playing the war on ITS terms! If this were a game, that would be one thing. But people are dying!!! And my friends and colleagues are dying!!! That’s at stake and when I have looked at the raw data (Dr. Lalezari has shared with me the UCLA and Montefiore data)- it is not the magic drug but it works better than anything else we have right now.
So release LERONLIMAB and save our loved ones, friends, and communities!
I just spend most of my nonclinical time fighting these obstinate doctors but I’ll keep fighting for my patients!
Read this and make your own judgements. I choose to trust doctors I know, etc. rather than some clown like Adam FF who's agenda is to further himself rather than putting his life on the line taking care of these patients.
Here is the advanced copy of Patterson's paper. It will be interesting to see if the MSM buries this after it's officially published. Again, a lot of the folks who say they want to help with this are a hell of lot more intersted in lining their own pockets than doing what's right for patients and caregivers. It will be interesting to see if the SA editors allow this to be published. it's one thing for politicians to have pay to play to hand out money for infrastructure, etc.; it's another thing to use pay to play to force doctors to use a drug on these patients that does not work. That's a totally new rubicon."

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vetology Reinvents AI Models for Veterinary Radiology

Updated Category News Views 3

Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...

Continue Reading
IRS Views Challenge Tax-Engineered Healthcare Schemes

Updated Category News Views 3

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 7

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
AI Ambassadors Rethink Arbitration's Future

Updated Category News Views 5

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Continue Reading
DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 3

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading
Digital Wine Atlas Maps 4.3 Million Vineyards Globally

Updated Category News Views 4

Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...

Continue Reading
Celebrate National Service Dog Month with Canine Companions

Updated Category News Views 5

A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...

Continue Reading
Sierra Ridge Advisors Join Gateway Financial Milestone

Updated Category News Views 5

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Continue Reading
Crimson Coward's Cheez Nugs Shake Up Fast-Casual Scene

Updated Category News Views 7

New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...

Continue Reading

Top 5 Most Recently Viewed Articles

Wabash Plans Earnings Call for Q3 2025 Review and Insights

Updated Category News Views 204

Wabash Schedules Earnings Conference Call for Q3 2025 LAFAYETTE, Ind. — Wabash (NYSE: WNC) has announced its upcoming quarterly earnings conference call. This important event will focus on reviewing the company’s financial results for the third quarter of 2025. Details of the Earnings Call The conference call is set to take place on a Thursday at 12:00 p.m. ET....

Continue Reading
Exploring zSpace's Innovative Augmented Reality for Education

Updated Category News Views 197

zSpace Expands AR/VR Learning Solutions zSpace, Inc. (NASDAQ: ZSPC), a renowned leader in immersive augmented reality (AR) learning solutions, has announced an exciting expansion of its Career and Technical Education (CTE) application suite. This announcement was made during the ACTE CareerTech VISION event, taking place soon in Nashville. Attendees visiting the zSpace...

Continue Reading
Innovative Launch of AURORRA by ARRIS Composites – Game Changer!

Updated Category News Views 511

ARRIS Composites Unveils AURORRA by ARRIS ARRIS Composites, a California-based advanced technology firm, is proud to announce the launch of its new direct-to-consumer brand, AURORRA by ARRIS (AXA). This brand introduces a collection of innovative and limited-edition products, designed primarily for those who thrive in dynamic activities. With an extensive background in...

Continue Reading
Hingham Schools Launch Innovative Electric Bus Initiative

Updated Category News Views 259

Hingham Public Schools Launches Innovative Electric Bus Initiative Hingham Public Schools is excited to announce a groundbreaking ceremony that marks a pivotal moment in the district's commitment to sustainability and modern educational transport. This initiative focuses on converting existing diesel school buses into electric ones, set to deliver a cleaner, quieter, and...

Continue Reading
Navigating Holiday Celebrations: The Realities of Alcohol Use

Updated Category News Views 160

The Importance of Understanding Alcohol's Impact During the Holidays Holidays are known for festive gatherings and joyful celebrations, but they can also lead to excessive drinking, posing significant risks. It’s during these times when some individuals may indulge more than they typically would, leading to potentially dangerous outcomes that could range from accidents...

Continue Reading